Biopreservation Market Size & Trends

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

·         Equipment

·         Freezers

·         Refrigerators

·         Consumables

·         Vials

·         Straws

·         Microtiter Plates

·         Bags

·         Liquid Nitrogen

·         Media

·         Pre-formulated

·         Home-brew

·         Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

·         Regenerative Medicine

·         Cell Therapy

·         Gene Therapy

·         Others

·         Bio-banking

·         Human Eggs

·         Human Sperms

·         Veterinary IVF

·         Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

·         US

·         Canada

Europe

·         Germany

·         UK

·         France

·         Italy

·         Spain

·         Denmark

·         Sweden

·         Norway

Asia Pacific

·         China

·         Japan

·         India

·         Australia

·         Thailand

·         South Korea

Latin America

·         Brazil

·         Mexico

·         Argentina

Middle East and Africa (MEA)

·         South Africa

·         Saudi Arabia

·         UAE

·         Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

·         Azenta US, Inc.

·         Biomatrica, Inc.

·         BioLife Solutions

·         MVE Biological Solutions

·         LabVantage Solutions, Inc.

·         Taylor-Wharton.

·         Thermo Fisher Scientific, Inc.

·         Panasonic Corporation

·         X-Therma Inc.

·         PrincetonCryo.

·         Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.